Concepedia

Cost–Effectiveness of Everolimus- Versus Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization (from the SPIRIT-IV Trial)

Amit P. Amin, Matthew R. Reynolds, Yang Lei, Elizabeth A. Magnuson, Katherine Vilain, Amy J. Durtschi, Charles A. Simonton, Gregg W. Stone, David J. Cohen

The American Journal of Cardiology · 2012 · 11 citations · 14 references

DOI

Concepts

References

14

Net Health Benefits

Aaron A. Stinnett, John Mullahy · Medical Decision Making · 1998 · 1.1K citations

, , +11

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone, Ali A. Rizvi, William Newman et al. · New England Journal of Medicine · 2010 · 896 citations · Full text

, , +15

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

Andrew Briggs, Paul Fenn · Health Economics · 1998 · 387 citations

, , +9

Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses

Ameet Bakhai, Chunxue Shi, Louise Githiora et al. · Circulation · 2004 · 236 citations · Full text

, , +12

Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents

Gregg W. Stone, Ali A. Rizvi, Krishnankutty Sudhir et al. · Journal of the American College of Cardiology · 2011 · 229 citations

, , +13